MedTrace Logo

CG Future® Annuloplasty Ring/Band Clinical Trial

NCT01074671 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2015-10-29

No results posted yet for this study

Summary

The primary goal of the study is to document the number of patients that are successfully implanted and benefit from the implantation of both a CG Future Annuloplasty ring or a band.

Conditions

  • Mitral Valve Insufficiency

Interventions

DEVICE

CG Future Annuloplasty Ring/Band

A CG Future Annuloplasty Ring or Band will be implanted, following standard care

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • D C Iliopoulos, Prof · Athens Medical Center, Greece

  • M Hendrikx, Dr · Virga Jesse Hospital, Hasselt, Belgium

  • K François, Dr · UZ Gent, Belgium

  • G El Khoury, Dr · Cliniques Universitaires Saint Luc, Brussels, Belgium

  • K Widenka, Dr · Szpital Wojewódzki Nr 2 w Rzeszowie, Poland

  • R. Haaverstad, Prof. · Haukeland Universitetssykehus, Bergen, Norway

  • K Matschke, Dr. · Technische Universitat Dresden, Germany

  • F Riess, Dr. · Albertinen Krankenhaus Hamburg, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Belgium
  • Germany
  • Greece
  • Norway
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01074671 on ClinicalTrials.gov